| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/04/2009 | US20090142320 METHOD TO MINIMIZE IL-17 PRODUCTION DURING nTREG CELL EXPANSION |
| 06/04/2009 | US20090142319 METHOD TO EXPAND nTREG CELLS USING PI-3K ANTAGONIST |
| 06/04/2009 | US20090142318 METHOD TO EXPAND nTREG CELLS USING p70 S6 KINASE ANTAGONIST |
| 06/04/2009 | US20090142317 Process for reducing effects of graft versus host disease using ex vivo expanded cd4+cd25+ regulatory t cells |
| 06/04/2009 | US20090142316 Use of Dendrimers to Stimulate Cell Growth |
| 06/04/2009 | US20090142315 Methods for the Dietary Management of Irritable Bowel Syndrome and Carbohydrate Malabsorption |
| 06/04/2009 | US20090142314 Maternal supplement |
| 06/04/2009 | US20090142313 Vaginal delivery system |
| 06/04/2009 | US20090142312 Methods for Promoting Wound Healing and Muscle Regeneration with the Cell Signaling Protein Nell1 |
| 06/04/2009 | US20090142311 Engineered intervertebral disc tissue |
| 06/04/2009 | US20090142310 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 06/04/2009 | US20090142309 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 06/04/2009 | US20090142307 Shape-Based Approach for Scaffoldless Tissue Engineering |
| 06/04/2009 | US20090142306 Methods and systems for treating ischemic tissues |
| 06/04/2009 | US20090142305 Pegylated fibrinogen-based biomatrix |
| 06/04/2009 | US20090142304 Composition for Improving Intestinal Flora |
| 06/04/2009 | US20090142303 Methods and compositions for dried cellular forms |
| 06/04/2009 | US20090142296 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 06/04/2009 | DE202009004147U1 Wässrige Salzlösung zu Inhalationszwecken Aqueous salt solution to inhalation purposes |
| 06/04/2009 | CA2851018A1 Lactic acid bacteria having action of lowering blood uric acid level |
| 06/04/2009 | CA2707187A1 Lactic acid bacterium having effect of lowering blood uric acid level |
| 06/04/2009 | CA2706800A1 Novel use |
| 06/04/2009 | CA2706750A1 Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors |
| 06/04/2009 | CA2706603A1 Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 06/04/2009 | CA2706560A1 Differentiation of human embryonic stem cells |
| 06/04/2009 | CA2706429A1 Compositions for treating an intestinal inflammatory condition |
| 06/04/2009 | CA2706415A1 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 06/04/2009 | CA2692765A1 Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua or adipose |
| 06/03/2009 | EP2065463A2 Survival and development of neural cells |
| 06/03/2009 | EP2065462A1 Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens |
| 06/03/2009 | EP2065048A1 Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation |
| 06/03/2009 | EP2064229A2 Oncolytic rhabdovirus |
| 06/03/2009 | EP2064216A2 Crystal form of epothilone b and use in pharmaceutical compositions |
| 06/03/2009 | EP2063902A1 Therapeutic cell medicine comprising skin tissue derived stem cell |
| 06/03/2009 | EP1435906B1 Method for producing biologically active products |
| 06/03/2009 | EP1131426B1 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 06/03/2009 | EP1012283B1 Mage-3 peptides presented by hla class ii molecules |
| 06/03/2009 | EP0833649B2 Methods of preventing or treating allergies |
| 06/03/2009 | EP0772677B1 T cell activation |
| 06/03/2009 | CN101444539A Use of strains of the parapox ovis virus against organ fibrosis |
| 06/03/2009 | CN101444538A Application of Escherichia coli and gene engineering bacteria thereof in preparing anti-liver-cancer solid tumor drugs |
| 06/03/2009 | CN101444537A Pharmaceutical application of black ceramic and pharmaceutical composition thereof |
| 06/03/2009 | CN101444536A Propolis micropill and preparation method thereof |
| 06/03/2009 | CN101444535A Method for manufacturing royal jelly powder capsule |
| 06/03/2009 | CN101444534A Psoriasis capsule |
| 06/03/2009 | CN101444533A Capsule of reinforced micro-element snake viscera tissue extract and formula process thereof |
| 06/03/2009 | CN101444532A Processing method for effectively dissolving out efficacy ingredient estrogen in deer fetus powder |
| 06/03/2009 | CN101444531A Deerhorn cap micro-shear transformation accessory ingredient interaction processing technique |
| 06/03/2009 | CN101444530A Pilose antler micro-shear transformation accessory ingredient interaction processing technique |
| 06/03/2009 | CN100494388C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/03/2009 | CN100494361C Skin cell with anti-inflammatory activity, and its preparing method and use for skin infective wound surface |
| 06/02/2009 | US7541446 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins |
| 06/02/2009 | US7541328 Coupling proteins to a modified polysaccharide |
| 06/02/2009 | US7541184 Activation and expansion of cells |
| 06/02/2009 | US7541183 Growth and differentiation of adult muscle stem cells with activators or inhibitors of Wnt signaling |
| 06/02/2009 | US7541179 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
| 06/02/2009 | US7541042 Topical compositions containing Bacillus coagulans extracellular products and uses thereof |
| 06/02/2009 | US7541025 Infusion of leukocytes into tumor; side efect reduction; then performing radiation therapy; prevent graft versus host disease |
| 06/02/2009 | CA2247388C Pharmaceutical composition comprising serum amyloid p component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components |
| 06/02/2009 | CA2178208C Purification of vitamin-k dependent proteins by membrane chromatography |
| 06/02/2009 | CA2158475C Composition and method for reducing toxicity of biologically-active factors |
| 05/28/2009 | WO2009067177A2 Bone morphogenic protein binding peptide |
| 05/28/2009 | WO2009066681A1 Lactic acid bacterium-containing preparation |
| 05/28/2009 | WO2009066537A1 Immunoregulatory function inducer and food composition |
| 05/28/2009 | WO2009066283A2 Calcium-mediated effects of coral and methods of use thereof |
| 05/28/2009 | WO2009065547A2 Poxviral oncolytic vectors |
| 05/28/2009 | WO2009046858A3 Therapeutic uses of kisspeptin 13 and compositions thereof |
| 05/28/2009 | WO2009026218A3 Identification and use of peptide inhibitors of protein synthesis |
| 05/28/2009 | WO2009023332A3 Device and method for purifying virally infected blood |
| 05/28/2009 | US20090138074 Decellularized extracellular matrix of conditioned body tissues and uses thereof |
| 05/28/2009 | US20090137468 Cytotoxic factors for modulating cell death |
| 05/28/2009 | US20090137040 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 05/28/2009 | US20090137017 Generation and isolation of antigen-specific t cells |
| 05/28/2009 | US20090136999 Compositions and methods for immunotherapy of cancer and infectious diseases |
| 05/28/2009 | US20090136917 Systems and methods for viral therapy |
| 05/28/2009 | US20090136604 Bacterial extracts cultured in thermal waters for treating sensitive skin, mucous membranes and scalps |
| 05/28/2009 | US20090136587 Pharmaceutical composition for the treatment of nerve damage comprising blood plasma or serum |
| 05/28/2009 | US20090136586 Method for Extracorporeal Removal of a Pathogenic Microbe, an Inflammatory Cell or an Inflammatory Protein From Blood |
| 05/28/2009 | US20090136576 Biocompatible composition for replacing/regenerating tissues |
| 05/28/2009 | US20090136567 Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic Escherichia Coli |
| 05/28/2009 | US20090136559 Chondrocyte Differentiation from Human Embryonic Stem Cells and Their Use in Tissue Engineering |
| 05/28/2009 | US20090136552 Growth factors nsg28, nsg30, and nsg32 |
| 05/28/2009 | US20090136531 HPV E6 protein T cell epitopes and uses thereof |
| 05/28/2009 | US20090136528 Novel immunogenic epitope for immunotherapy |
| 05/28/2009 | US20090136521 Method for Selectively Depleting Hypoxic Cells |
| 05/28/2009 | US20090136515 Methods of diagnosing, preventing and treating infection with Hepatitis C virus |
| 05/28/2009 | US20090136508 Method of diagnosing colon and gastric cancers |
| 05/28/2009 | US20090136507 HBM variants that modulate bone mass and lipid levels |
| 05/28/2009 | US20090136488 Inhibition of cancer metastasis |
| 05/28/2009 | US20090136471 Treatment of premature birth complications |
| 05/28/2009 | US20090136470 Regulatory t cells and methods of making and using same |
| 05/28/2009 | US20090136469 Formulation for oral administration with beneficial effects on the cardiovascular system |
| 05/28/2009 | US20090136468 Peri-operative composition comprising lactobacillus rhamnosus |
| 05/28/2009 | US20090136467 Apolipoprotein analogues |
| 05/28/2009 | US20090136466 Methods for making skin cell derived stem cells |
| 05/28/2009 | US20090136465 Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof |
| 05/28/2009 | US20090136464 Methods and compositions for cell therapy |
| 05/28/2009 | US20090136463 Schwann Cell Bridge Implants and Phosphodiesterase Inhibitors to Stimulate CNS Nerve Regeneration |
| 05/28/2009 | US20090136462 Peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen, Prostate acid phosphatase and Prostate specific membrane antigen, BA-46, Mucin, and Teratocarcinoma-derived growth factor; bladder, prostate and breast cancers; antimetastasis agents |
| 05/28/2009 | US20090136461 Neuronal differentiation method of adult stem cells using small molecules |